Shanghai Rightongene Biotechnology Co., Ltd. Stock: price and insider trades · China
睿昂基因
Shanghai Rightongene Biotechnology Co., Ltd.: what insiders have been doing
Shanghai Rightongene Biotechnology Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). No insider at Shanghai Rightongene Biotechnology Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 12 September 2023.
The full history, which starts in 2023, counts no purchases against 2 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Shanghai Rightongene Biotechnology Co., Ltd.
睿昂基因 is a company focused on the health and pharmaceutical sector, specializing in the development of innovative genetic solutions. It is listed on the Shanghai Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
